alex azar

Alex Michael Azar II (born June 17, 1967) is the former Deputy Secretary of the U.S. Department of Health and Human Services (HHS) under George W. Bush (2005-2007) and President of Lilly USA, LLC, the largest affiliate of global biopharmaceutical leader Eli Lilly and Company from 2012–2017. Azar was nominated on November 13, 2017, to be Secretary of Health and Human Services by President Trump. Wikipedia
Washington Post Tue, 11/14/2017 - 14:04

Analysis: Whether Roy Moore wins or loses, there is no good outcome for Senate Republicans
Republicans face a lose-lose situation in the Alabama Senate race
View more 120 likes - 17 shares - 12 comments
USA TODAY Tue, 11/14/2017 - 03:03

Trump picks former pharmaceutical exec Alex Azar as his next Health secretary
BREAKING: Trump says he will nominate former pharmaceutical executive Alex Azar to be next secretary of health and human services.
View more 335 likes - 58 shares - 5 comments
Washington Post Mon, 11/13/2017 - 22:53

Opinion | Trump told voters the system was rigged. Now he’s actively rigging it against them.
"When he said he'd change things, he didn't mention he'd be making them worse," writes Paul Waldman in Opinion.
View more 450 likes - 119 shares - 12 comments
New York Daily News Mon, 11/13/2017 - 21:42

Trump picks former pharmaceutical executive Alex Azar as health chief
Meet Tom Price's replacement.
View more 19 likes - 19 shares - 7 comments
The Wall Street Journal Mon, 11/13/2017 - 21:32

Trump Nominates Alex Azar as Health and Human Services Secretary
Alex Azar had been considered to be potentially controversial for his stint at Eli Lilly at a time when drug prices have become a source of contention for some.
View more 30 likes - 37 shares - 11 comments
Los Angeles Times Mon, 11/13/2017 - 21:27

Trump nominates former pharmaceutical executive Alex Azar as new Health and Human Services secretary
The former Eli Lilly executive will replace Tom Price, who resigned after being criticized for spending $400,000 in taxpayer money on private flights.
View more 23 likes - 34 shares - 5 comments